VR Adviser, LLC Diversified Active

CIK: 0001615982 · Show all filings

Period: Q2 2022 (← Previous) (Next →)

Filing Date: May 15, 2023

Total Value ($000): $507,777 (100.0% shares, 0.0% debt)

Holdings (27)

— Tricida Inc 13.6%

Value ($000) $69,039 Shares 7,132,079 Est. Cost $9.15 Unrealized —

ACRS Aclaris Therapeutics Inc 12.5%

Value ($000) $63,713 Shares 4,563,962 Est. Cost $13.57 Unrealized +3.3%

RLMD Relmada Therapeutics Inc 8.5%

Value ($000) $43,109 Shares 2,270,072 Est. Cost $31.54 Unrealized -30.8%

TVTX Travere Therapeutics Inc 8.2%

Value ($000) $41,460 Shares 1,711,102 Est. Cost $19.66 Unrealized +27.9%

COGT Cogent Biosciences Inc 7.2%

Value ($000) $36,424 Shares 4,038,117 Est. Cost $7.95 Unrealized -14.1%

GHRS GH Research PLC 6.3%

Value ($000) $31,792 Shares 3,185,573 Est. Cost $17.93 Unrealized -27.5%

— Instil Bio Inc 5.5%

Value ($000) $27,709 Shares 5,997,657 Est. Cost $25.08 Unrealized —

CLDX Celldex Therapeutics Inc 4.6%

Value ($000) $23,324 Shares 865,116 Est. Cost $15.71 Unrealized +84.9%

VRDN Viridian Therapeutics Inc 4.2%

Value ($000) $21,438 Shares 1,852,919 Est. Cost $18.59 Unrealized -27.7%

— VistaGen Therapeutics Inc 3.6%

Value ($000) $18,214 Shares 20,697,286 Est. Cost $1.76 Unrealized —

— Marinus Pharmaceuticals Inc 3.0%

Value ($000) $15,279 Shares 3,156,803 Est. Cost $11.98 Unrealized —

WHWK Aadi Bioscience Inc 2.8%

Value ($000) $14,458 Shares 1,173,518 Est. Cost $30.48 Unrealized -51.3%

— Inozyme Pharma Inc 2.5%

Value ($000) $12,927 Shares 2,709,987 Est. Cost $4.77 Unrealized —

— Akouos Inc 2.5%

Value ($000) $12,509 Shares 2,667,119 Est. Cost $4.69 Unrealized —

LIANY LianBio 2.3%

Value ($000) $11,617 Shares 5,378,341 Est. Cost $6.16 Unrealized —

— Aerovate Therapeutics Inc 1.8%

Value ($000) $9,228 Shares 590,408 Est. Cost $16.32 Unrealized —

TRVI Trevi Therapeutics Inc 1.7%

Value ($000) $8,571 Shares 3,050,022 Est. Cost $2.46 Unrealized 0.0%

— Chinook Therapeutics Inc 1.7%

Value ($000) $8,563 Shares 489,618 Est. Cost $16.31 Unrealized —

ANNX Annexon Inc 1.4%

Value ($000) $7,270 Shares 1,928,477 Est. Cost $3.06 Unrealized 0.0%

SVRA Savara Inc 1.2%

Value ($000) $6,259 Shares 4,117,530 Est. Cost $1.26 Unrealized +4.0%

— Lyra Therapeutics Inc 1.0%

Value ($000) $5,222 Shares 924,170 Est. Cost $5.65 Unrealized —

— Provention Bio Inc 0.9%

Value ($000) $4,475 Shares 1,118,653 Est. Cost $7.32 Unrealized —

ALT Altimmune Inc 0.9%

Value ($000) $4,321 Shares 369,306 Est. Cost $7.36 Unrealized -16.3%

ATYR aTyr Pharma Inc 0.8%

Value ($000) $3,959 Shares 1,398,889 Est. Cost $5.98 Unrealized -39.6%

— Affimed NV 0.8%

Value ($000) $3,957 Shares 1,428,571 Est. Cost $5.52 Unrealized —

— Rallybio Corp 0.4%

Value ($000) $2,027 Shares 268,532 Est. Cost $7.55 Unrealized —

XENE Xenon Pharmaceuticals Inc 0.2%

Value ($000) $913 Shares 30,000 Est. Cost $30.24 Unrealized 0.0%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	Tricida Inc	7,132,079	$69,039	13.6%	$9.15	—	COM	89610F101
ACRS	Aclaris Therapeutics Inc	4,563,962	$63,713	12.5%	$13.57	+3.3%	COM	00461U105
RLMD	Relmada Therapeutics Inc	2,270,072	$43,109	8.5%	$31.54	-30.8%	COM	75955J402
TVTX	Travere Therapeutics Inc	1,711,102	$41,460	8.2%	$19.66	+27.9%	COM	89422G107
COGT	Cogent Biosciences Inc	4,038,117	$36,424	7.2%	$7.95	-14.1%	COM	19240Q201
GHRS	GH Research PLC	3,185,573	$31,792	6.3%	$17.93	-27.5%	ORD SH	G3855L106
—	Instil Bio Inc	5,997,657	$27,709	5.5%	$25.08	—	COM	45783C101
CLDX	Celldex Therapeutics Inc	865,116	$23,324	4.6%	$15.71	+84.9%	COM	15117B202
VRDN	Viridian Therapeutics Inc	1,852,919	$21,438	4.2%	$18.59	-27.7%	COM	92790C104
—	VistaGen Therapeutics Inc	20,697,286	$18,214	3.6%	$1.76	—	COM	92840H202
—	Marinus Pharmaceuticals Inc	3,156,803	$15,279	3.0%	$11.98	—	COM	56854Q200
WHWK	Aadi Bioscience Inc	1,173,518	$14,458	2.8%	$30.48	-51.3%	COM	00032Q104
—	Inozyme Pharma Inc	2,709,987	$12,927	2.5%	$4.77	—	COM	45790W108
—	Akouos Inc	2,667,119	$12,509	2.5%	$4.69	—	COM	00973J101
LIANY	LianBio	5,378,341	$11,617	2.3%	$6.16	—	SPONS ADR	53000N108
—	Aerovate Therapeutics Inc	590,408	$9,228	1.8%	$16.32	—	COM	008064107
TRVI	Trevi Therapeutics Inc	3,050,022	$8,571	1.7%	$2.46	0.0%	COM	89532M101
—	Chinook Therapeutics Inc	489,618	$8,563	1.7%	$16.31	—	COM	16961L106
ANNX	Annexon Inc	1,928,477	$7,270	1.4%	$3.06	0.0%	COM	03589W102
SVRA	Savara Inc	4,117,530	$6,259	1.2%	$1.26	+4.0%	COM	805111101
—	Lyra Therapeutics Inc	924,170	$5,222	1.0%	$5.65	—	COM	55234L105
—	Provention Bio Inc	1,118,653	$4,475	0.9%	$7.32	—	COM	74374N102
ALT	Altimmune Inc	369,306	$4,321	0.9%	$7.36	-16.3%	COM	02155H200
ATYR	aTyr Pharma Inc	1,398,889	$3,959	0.8%	$5.98	-39.6%	COM	002120202
—	Affimed NV	1,428,571	$3,957	0.8%	$5.52	—	COM	N01045108
—	Rallybio Corp	268,532	$2,027	0.4%	$7.55	—	COM	75120L100
XENE	Xenon Pharmaceuticals Inc	30,000	$913	0.2%	$30.24	0.0%	COM	98420N105